A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)

被引：0
|
作者：
Grivas, P. [1 ]
Sridhar, S. [2 ]
Perez Valderrama, B. [3 ]
Castellano Gauna, D. E. [4 ]
Loriot, Y. [5 ]
Doger de Speville, B. [6 ]
Pouessel, D. [7 ]
van der Heijden, M. S. [8 ]
Galsky, M. D. [9 ]
Gulati, S. [10 ]
Ravaud, A. [11 ]
Fontana, E. [12 ]
Spira, A. I. [13 ]
Gartrell, B. A. [14 ]
Mortazavi, A. [15 ]
Isambert, N. [16 ]
Baxter, D. [17 ]
Powles, T. B. [18 ]
Khaled, A. H. [19 ]
Morales Barrera, R. [20 ]
机构：
[1] Univ Washington, Dept Med Oncol, Seattle Canc Care Alliance, Seattle, WA USA
[2] UHN, Dept Med Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
[4] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
[5] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Univ Hosp Fdn Jimenez Diaz, Start Madrid Phase 1 Unit, Madrid, Spain
[7] Icr Iuct Oncopole, Dept Med Oncol, Toulouse, France
[8] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] Icahn Sch Med, Tisch Canc Inst, Mt Sinai Hosp, New York, NY USA
[10] UC Davis Comprehens Canc Ctr, Hematol & Oncol Dept, Sacramento, CA USA
[11] CHU Bordeaux Hop St Andre, Dept Med Oncol, Bordeaux, France
[12] Sarah Cannon Res Inst SCRI UK, Drug Dev, London, England
[13] Virginia Canc Specialist, Res Inst, Fairfax, VA USA
[14] Montefiore Einstein Ctr Canc Care, Oncol & Urol, Bronx, NY USA
[15] Ohio State Univ, Med Oncol Dept, Wexner Med Ctr, Columbus, OH USA
[16] CHU Poitiers, Dept Med Oncol, Jean Bernard Hop, Poitiers, France
[17] GSK USA, Collegeville, PA USA
[18] St Bartholomews Hosp Barts Hlth NHS Trust, Dept Oncol, London, England
[19] GSK USA, Dept Oncol, Collegeville, PA USA
[20] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2374P
引用
收藏
页码：S1209 / S1210
页数：2
相关论文
共 50 条
  • [41] The efficacy and safety of sequential use of anlotinib and 131I for locally advanced or metastatic differentiated thyroid cancer: A single-arm phase II clinical trial
    Song, Hongjun
    Qiu, Xian
    He, Ziyan
    Chen, Libo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Camrelizumab plus famitinib malate in patients with advanced renal cell cancer and unresectable urothelial carcinoma: A multicenter, open-label, single-arm, phase II trial.
    Qu, Yuan-Yuan
    Guo, Hongqian
    Luo, Hong
    Zou, Qing
    Xing, Ninazeng
    Sun, Zhongquan
    Zhang, Xuepei
    Xia, Shujie
    He, Chaohong
    Zhang, Hailiang
    Cai, Jinling
    Zhang, Xiao
    Wang, Quanren
    Ye, Dingwei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma (RICE): A Prospective, Single-Arm, Phase II Trial
    Lin, L.
    Li, H.
    Zhao, L.
    Cheng, Y.
    Liu, M. N.
    Fu, X.
    Liu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E464 - E465
  • [44] ABLE: single-arm trial of nab-paclitaxel with ANTI-PD1 in advanced urothelial cancer
    Brown, Jason
    Daignault, Stephanie
    Reichert, Zachery R.
    Palmbos, Phillip Lee
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [45] Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma
    Barker, Christopher A.
    Dufault, Suzanne
    Arron, Sarah T.
    Ho, Alan L.
    Algazi, Alain P.
    Dunn, Lara A.
    Humphries, Audrey A.
    Hultman, Carter
    Lian, Ming
    Knott, P. Daniel
    Yom, Sue S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (19) : 2327 - 2335
  • [46] Single-arm phase ib/II study of durvalumab and guadecitabine in advanced kidney cancer (NCT03308396).
    Yentz, Sarah Elizabeth
    Reimers, Melissa Andrea
    Joshi, Monika
    Zakharia, Yousef
    Gupta, Shilpa
    Singer, Eric A.
    Daignault, Stephanie
    Zou, Weiping
    Musapatika, Dana
    Alva, Ajjai Shivaram
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [47] A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
    Liu, Ting
    Li, Qing
    Lin, Zhen
    Liu, Chunhua
    Pu, Wei
    Zeng, Shasha
    Lai, Jun
    Cai, Xuebin
    Zhang, Lisha
    Wang, Shuyang
    Chen, Miao
    Cao, Wei
    Gou, Hongfeng
    Zhu, Qing
    CANCER RESEARCH AND TREATMENT, 2024, 56 (02): : 602 - 615
  • [48] Atezolizumab (ATZ) with split-doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA): A multicentre, single-arm phase II trial
    Oria, G. A. De Velasco
    Garcia-Carbonero, I.
    Esteban-Gonzalez, E.
    Pinto, A.
    Lorente, D.
    De Liano, A. Gomez
    Ortega, E. Martinez
    Colomo, L. Jimenez
    Puente, J.
    Gonzalez, I.
    Fernandez, O.
    Anguera, G.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1333 - S1333
  • [49] Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 Trial
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2016, 196 (06): : 1637 - 1638
  • [50] Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma who have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicenter, Phase 2 Trial
    Bochner, Bernard H.
    EUROPEAN UROLOGY, 2017, 71 (02) : 299 - 300
12345